HOUSTON, April 1 /PRNewswire/ -- Beginning in March, SpectraCell Laboratories added the HS-Omega-3 Index(R) test to its test menu. This test measures the amount of two very important fatty acids called EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in a person’s red blood cells. Red blood cell fatty acid composition reflects long-term intake of EPA and DHA, and are also highly correlated with the amount of fatty acids found in heart tissue. The higher the content of the fatty acids, EPA and DHA, the lower the risk of a fatal heart attack.
“So many people are taking fish oils or omega-3 fatty acid supplements nowadays. People want to know if these supplements are being absorbed and utilized by their body efficiently, or if they are taking the correct dosage,” comments Dr. Fred Crawford, Vice President of Operations and Laboratory Director for SpectraCell. “This test finally allows a person to monitor their omega 3 status.”
About SpectraCell Laboratories - SpectraCell is a CLIA accredited laboratory that services healthcare providers nationwide by providing advanced clinical testing with micronutrient testing and the Lipoprotein Particle Profile(TM) (LPP(TM)).
SpectraCell’s Lipoprotein Particle Profile(TM) is the most advanced lipoprotein test available. Unlike traditional cholesterol tests, SpectraCell’s LPP(TM) directly measures both the size (density) and number of several classes of lipoprotein particles providing an accurate assessment of cardiovascular risk.
CONTACT: Otto Schaefer, Vice President, Sales and Marketing of SpectraCell
Laboratories, 1-800-227-5227, Fax +1-713-621-3234
Web site: http://www.spectracell.com/
